Fukuoka, Japan

Kenichi Okubo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Miyarisan Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenichi Okubo. Retrieved from https://idiyas.com/inventor/kenichi-okubo-c2obcfm8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenichi Okubo: Innovator in Peptide Research

Introduction

Kenichi Okubo is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of solutions to combat health issues caused by certain bacteria.

Latest Patents

Okubo holds a patent for a peptide that inhibits the production of toxins by bacteria belonging to the genus Clostridium. This innovation aims to provide a means for preventing, treating, and controlling health damages, including food poisoning and infections. The cyclic peptide he developed contains the sequence Cys-Phe-Trp-Ala-His, which plays a crucial role in its effectiveness.

Career Highlights

Throughout his career, Okubo has focused on advancing medical research and developing practical applications for his discoveries. His work has the potential to significantly impact public health by addressing bacterial infections and food safety.

Collaborations

Okubo has collaborated with esteemed colleagues, including Tohru Shimizu and Kaori Ohtani, to further enhance his research and innovations.

Conclusion

Kenichi Okubo's contributions to peptide research exemplify the importance of innovation in addressing health challenges. His work continues to pave the way for advancements in medical science and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…